Literature DB >> 10092784

Regulation of lymphotoxin production by the p21ras-raf-MEK-ERK cascade in PHA/PMA-stimulated Jurkat cells.

Y Q Li1, C S Hii, M Costabile, D Goh, C J Der, A Ferrante.   

Abstract

Although the production of lymphotoxin (LT) from activated Th1 lymphocytes has been reported extensively, the intracellular signaling mechanisms that regulate this T cell function remain totally undefined. We have examined whether the p21ras-raf-1-mitogen-activated protein kinase/extracellular signal-regulated protein kinase (ERK) kinase (MEK)-ERK cascade plays a role in regulating the production of LT, because the activity of these signaling molecules is up-regulated in activated T lymphocytes. Transfection of Jurkat leukemic T cells with a dominant negative mutant of p21ras (ras17N or ras15A), raf-1 (raf 1-130), or ERK1 (Erk1-K71R) resulted in the suppression of the mitogen/phorbol ester-stimulated production/secretion of LT. This suppression was accompanied by a parallel inhibition of mitogen-stimulated ERK activation. The selective antagonist of MEK1 activation, PD98059, also attenuated the mitogen-stimulated or anti-CD3 Ab and phorbol ester-stimulated production of LT from Jurkat cells or peripheral blood T lymphocytes. This study provides, for the first time, direct evidence that the p21ras-raf-MEK-ERK cascade plays a vital role in regulating the production of LT.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10092784

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  Selective deficiency in protein kinase C isoenzyme expression and inadequacy in mitogen-activated protein kinase activation in cord blood T cells.

Authors:  Charles S T Hii; Maurizio Costabile; George C Mayne; Channing J Der; Andrew W Murray; Antonio Ferrante
Journal:  Biochem J       Date:  2003-03-01       Impact factor: 3.857

2.  An adenoviral vector for probing promoter activity in primary immune cells.

Authors:  Pulak Tripathi; Rajat Madan; Claire Chougnet; Senad Divanovic; Xiaojing Ma; Larry M Wahl; Thomas Gajewski; Christopher L Karp; David A Hildeman
Journal:  J Immunol Methods       Date:  2006-02-20       Impact factor: 2.303

3.  mTORC1 activation in B cells confers impairment of marginal zone microarchitecture by exaggerating cathepsin activity.

Authors:  Naresh Kumar Meena; Shakti Prasad Pattanayak; Yael Ben-Nun; Sandrine Benhamron; Saran Kumar; Emmanuelle Merquiol; Nadine Hövelmeyer; Galia Blum; Boaz Tirosh
Journal:  Immunology       Date:  2018-09-16       Impact factor: 7.397

4.  Macrophage differentiation increases expression of the ascorbate transporter (SVCT2).

Authors:  Huan Qiao; James M May
Journal:  Free Radic Biol Med       Date:  2009-02-27       Impact factor: 7.376

5.  Loureirin B, an essential component of Sanguis Draxonis, inhibits Kv1.3 channel and suppresses cytokine release from Jurkat T cells.

Authors:  Shijin Yin; Qinglan Hu; Jialie Luo; Yuxin Li; Chunlan Lu; Xuan Chen; Hongzhen Hu
Journal:  Cell Biosci       Date:  2014-12-12       Impact factor: 7.133

6.  Diacylglycerol metabolism attenuates T-cell receptor signaling and alters thymocyte differentiation.

Authors:  M Almena; E Andrada; R Liebana; I Merida
Journal:  Cell Death Dis       Date:  2013-11-07       Impact factor: 8.469

7.  The Role of ERK Signaling in Experimental Autoimmune Encephalomyelitis.

Authors:  Katharina Birkner; Beatrice Wasser; Julia Loos; Alexander Plotnikov; Rony Seger; Frauke Zipp; Esther Witsch; Stefan Bittner
Journal:  Int J Mol Sci       Date:  2017-09-15       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.